Cargando…
Evaluation of Madurahydroxylactone as a Slow Release Antibacterial Implant Coating
Madurahydroxylactone (MHL), a secondary metabolite with antibacterial activity was evaluated for its suitability to generate controlled drug release coatings on medical implant materials. A smooth and firmly attached layer could be produced from a precursor solution on various metallic implant mater...
Autores principales: | Badar, Muhammad, Hemmen, Katherina, Nimtz, Manfred, Stieve, Martin, Stiesch, Meike, Lenarz, Thomas, Hauser, Hansjörg, Möllmann, Ute, Vogt, Sebastian, Schnabelrauch, Matthias, Mueller, Peter P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102426/ https://www.ncbi.nlm.nih.gov/pubmed/21625377 http://dx.doi.org/10.2174/1874120701004010263 |
Ejemplares similares
-
Comparable Studies on Nanoscale Antibacterial Polymer Coatings Based on Different Coating Procedures
por: Laube, Thorsten, et al.
Publicado: (2022) -
Introducing a Semi-Coated Model to Investigate Antibacterial Effects of Biocompatible Polymers on Titanium Surfaces
por: Winkel, Andreas, et al.
Publicado: (2015) -
Enzyme-Responsive Nanoparticles and Coatings Made from Alginate/Peptide Ciprofloxacin Conjugates as Drug Release System
por: Bourgat, Yannick, et al.
Publicado: (2021) -
Antibacterial Effect of Cupral(®) on Oral Biofilms - An In-Vitro Study
por: Von Maltzahn, Nadine Freifrau, et al.
Publicado: (2020) -
Biocompatible Coatings from Smart Biopolymer Nanoparticles for Enzymatically Induced Drug Release
por: Tolle, Christian, et al.
Publicado: (2018)